<SEC-DOCUMENT>0000950170-23-041515-index.html : 20230811 <SEC-HEADER>0000950170-23-041515.hdr.sgml : 20230811 <ACCEPTANCE-DATETIME>20230810182858 ACCESSION NUMBER: 0000950170-23-041515 CONFORMED SUBMISSION TYPE: S-8 PUBLIC DOCUMENT COUNT: 6 FILED AS OF DATE: 20230811 DATE AS OF CHANGE: 20230810 EFFECTIVENESS DATE: 20230811 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Eledon Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001404281 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-8 SEC ACT: 1933 Act SEC FILE NUMBER: 333-273900 FILM NUMBER: 231161023 BUSINESS ADDRESS: STREET 1: 19900 MACARTHUR BLVD. STREET 2: SUITE 550 CITY: IRVINE STATE: CA ZIP: 92612 BUSINESS PHONE: 949-238-8090 MAIL ADDRESS: STREET 1: 19900 MACARTHUR BLVD. STREET 2: SUITE 550 CITY: IRVINE STATE: CA ZIP: 92612 FORMER COMPANY: FORMER CONFORMED NAME: Novus Therapeutics, Inc. DATE OF NAME CHANGE: 20170511 FORMER COMPANY: FORMER CONFORMED NAME: Tokai Pharmaceuticals Inc DATE OF NAME CHANGE: 20070622 </SEC-HEADER> <DOCUMENT> <TYPE>S-8 <SEQUENCE>1 <FILENAME>eldn_2023.08_s-8.htm <DESCRIPTION>S-8 <TEXT> Document 1 - file: eldn_2023.08_s-8.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>2 <FILENAME>eldn-ex5_1.htm <DESCRIPTION>EX-5.1 <TEXT> Document 2 - file: eldn-ex5_1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>3 <FILENAME>eldn-ex23_1.htm <DESCRIPTION>EX-23.1 <TEXT> Document 3 - file: eldn-ex23_1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-24.1 <SEQUENCE>4 <FILENAME>eldn-ex24_1.htm <DESCRIPTION>EX-24.1 <TEXT> Document 4 - file: eldn-ex24_1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-FILING FEES <SEQUENCE>5 <FILENAME>eldn-exfiling_fees.htm <DESCRIPTION>EX-FILING FEES <TEXT> Document 5 - file: eldn-exfiling_fees.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>img24513963_0.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 6 - file: img24513963_0.jpg
</DOCUMENT> </SEC-DOCUMENT>